Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Assessing Safety and Antiretroviral Activity of Intravenously Administered LTB4 in HIV-1 Infected Adults With a CD4 Count Greater Than 250 Cells/mm3 and a Viral Load Greater Than 5,000 Copies/mL, and Who Have Not Received Antiretroviral Therapy Within Two Months

NCT00251537 is registered in ClinicalTrials.gov with LTB4 Sweden AB as lead sponsor.

NCT NCT00251537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00251537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Assessing Safety and Antiretroviral Activity of Intravenously Administered LTB4 in HIV-1 Infected Adults With a CD4 Count Greater Than 250 Cells/mm3 and a Viral Load Greater Than 5,000 Copies/mL, and Who Have Not Received Antiretroviral Therapy Within Two Months
Lead sponsor
LTB4 Sweden AB
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
August 31, 2006
Enrollment
40
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections